Literature DB >> 22024388

Cancer prevalence and mortality in centenarians: a systematic review.

Nicholas Pavlidis1, Giorgio Stanta, Riccardo A Audisio.   

Abstract

Life expectancy has dramatically expanded, the global population has aged unprecedentedly and the number of centenarians has significantly increased. The analysis of autopsy series, cancer registries data, vital statistics and surveys specific to this age group allows unique observations with respect to incidence and prevalence, cause of death by cancer, frequency of primary tumours, metastatic patterns, occurrence of incidental cancers and of multiple primary tumours. Data analysis demonstrates how cancer incidence and cause of death present a threefold decrease after age 90 and reach 0-4% above age 100. In addition, the number of metastatic sites are remarkably less and incidental malignant tumours or multiple primary cancers are more frequent, indicating that cancer in centenarians carries a more indolent behaviour. The unique features of malignant tumours in this population is hereby presented and discussed following a systematic review of the available literature. Cancer in the very elderly is relatively uncommon as a disease and as a cause of death. It is characterized by a slow growth and a modest life-threatening potential.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22024388     DOI: 10.1016/j.critrevonc.2011.09.007

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  26 in total

1.  Acute myeloid leukemia in very old patients.

Authors:  Vladimir Lj Lazarevic; Anders Bredberg; Fryderyk Lorenz; Emma Öhlander; Petar Antunovic; Jörg Cammenga; Lovisa Wennström; Lars Möllgård; Stefan Deneberg; Åsa Derolf; Martin Höglund; Gunnar Juliusson
Journal:  Haematologica       Date:  2018-06-28       Impact factor: 9.941

Review 2.  Cancer-Incidence, prevalence and mortality in the oldest-old. A comprehensive review.

Authors:  Shantell C Nolen; Marcella A Evans; Avital Fischer; Maria M Corrada; Claudia H Kawas; Daniela A Bota
Journal:  Mech Ageing Dev       Date:  2017-05-11       Impact factor: 5.432

Review 3.  Oxidative stress and the ageing endocrine system.

Authors:  Giovanni Vitale; Stefano Salvioli; Claudio Franceschi
Journal:  Nat Rev Endocrinol       Date:  2013-02-26       Impact factor: 43.330

Review 4.  The key role of growth hormone-insulin-IGF-1 signaling in aging and cancer.

Authors:  Vladimir N Anisimov; Andrzej Bartke
Journal:  Crit Rev Oncol Hematol       Date:  2013-02-21       Impact factor: 6.312

Review 5.  Cancer and Alzheimer's disease inverse relationship: an age-associated diverging derailment of shared pathways.

Authors:  Cristina Lanni; Mirco Masi; Marco Racchi; Stefano Govoni
Journal:  Mol Psychiatry       Date:  2020-05-07       Impact factor: 15.992

6.  Age and cancer risk: a potentially modifiable relationship.

Authors:  Mary C White; Dawn M Holman; Jennifer E Boehm; Lucy A Peipins; Melissa Grossman; S Jane Henley
Journal:  Am J Prev Med       Date:  2014-03       Impact factor: 5.043

7.  B16/F10 tumors in aged 3D collagen in vitro simulate tumor growth and gene expression in aged mice in vivo.

Authors:  Itay Bentov; Mamatha Damodarasamy; Stephen Plymate; May J Reed
Journal:  In Vitro Cell Dev Biol Anim       Date:  2013-05-10       Impact factor: 2.416

8.  Cancer treatment in the extreme elderly: case study of a 100-year-old lymphoma patient.

Authors:  Peter J Gilbar; Howard Mutsando; Joshua P Richmond; Ronald B Middleton
Journal:  Int J Hematol Oncol       Date:  2016-08-19

Review 9.  Diametrical diseases reflect evolutionary-genetic tradeoffs: Evidence from psychiatry, neurology, rheumatology, oncology and immunology.

Authors:  Bernard J Crespi; Matthew C Go
Journal:  Evol Med Public Health       Date:  2015-09-09

10.  Whole-genome sequencing of the world's oldest people.

Authors:  Hinco J Gierman; Kristen Fortney; Jared C Roach; Natalie S Coles; Hong Li; Gustavo Glusman; Glenn J Markov; Justin D Smith; Leroy Hood; L Stephen Coles; Stuart K Kim
Journal:  PLoS One       Date:  2014-11-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.